MedTrace Logo

Leucine-enriched Formulas in Patients With Tumor-induced Sarcopenia

NCT05837741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-05-09

No results posted yet for this study

Summary

Currently there is a lack of evidence for recommending specific oral supplements (OS) for nutritional support in patients with cancer, including leucine-enriched supplements.

Conditions

Interventions

DIETARY_SUPPLEMENT

Standard hypercaloric hyperproteic oral nutritional supplement

Patients will receive nutritional support with Standard hypercaloric hyperproteic oral nutritional supplement

DIETARY_SUPPLEMENT

Leucine-enriched hypercaloric hyperproteic oral nutritional supplement

Patients will receive nutritional support with Leucine-enriched hypercaloric hyperproteic oral nutritional supplement

Sponsors & Collaborators

  • Maimónides Biomedical Research Institute of Córdoba

    lead OTHER

Principal Investigators

  • Aura D Herrera Martinez, PhD · IMIBIC-HURS

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-08-01
Completion
2021-11-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05837741 on ClinicalTrials.gov